218 related articles for article (PubMed ID: 23291092)
1. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
[TBL] [Abstract][Full Text] [Related]
2. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
Pan WK; Li P; Guo ZT; Huang Q; Gao Y
Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
[TBL] [Abstract][Full Text] [Related]
3. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy.
Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX
Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679
[TBL] [Abstract][Full Text] [Related]
4. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
Holmes WJ; Mishra A; Gorst C; Liew SH
J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
[TBL] [Abstract][Full Text] [Related]
5. Propranolol therapy for infantile haemangiomas: review of the literature.
Zimmermann AP; Wiegand S; Werner JA; Eivazi B
Int J Pediatr Otorhinolaryngol; 2010 Apr; 74(4):338-42. PubMed ID: 20117846
[TBL] [Abstract][Full Text] [Related]
6. Successful management of airway hemangioma with propranolol.
Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
[TBL] [Abstract][Full Text] [Related]
7. [Expression of serum and urinary vascular endothelial growth factor-A and epidermal growth factor-like domain 7 in proliferating hemangioma treated with propranolol].
Bin L; Manli C; Jie L; Xiaopeng Y; Zhaoquan L; Zhongcheng G
Hua Xi Kou Qiang Yi Xue Za Zhi; 2014 Oct; 32(5):441-5. PubMed ID: 25490818
[TBL] [Abstract][Full Text] [Related]
8. [The change of serum vascular endothelial growth factor and matrix metalloproteinases-9 in proliferative hemangioma treated with propranolol].
Zhao ZF; Lü RR; Huo R; Fu HB; Xu GQ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Sep; 27(5):359-61. PubMed ID: 22259987
[TBL] [Abstract][Full Text] [Related]
9. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
[TBL] [Abstract][Full Text] [Related]
10. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.
Storch CH; Hoeger PH
Br J Dermatol; 2010 Aug; 163(2):269-74. PubMed ID: 20456345
[TBL] [Abstract][Full Text] [Related]
11. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
Phillips RJ; Penington AJ; Bekhor PS; Crock CM
J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
[TBL] [Abstract][Full Text] [Related]
12. Propranolol for infantile hemangioma: Effect on plasma vascular endothelial growth factor.
Ozeki M; Nozawa A; Hori T; Kanda K; Kimura T; Kawamoto N; Fukao T
Pediatr Int; 2016 Nov; 58(11):1130-1135. PubMed ID: 26991797
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
Thoumazet F; Léauté-Labrèze C; Colin J; Mortemousque B
Br J Ophthalmol; 2012 Mar; 96(3):370-4. PubMed ID: 21673014
[TBL] [Abstract][Full Text] [Related]
14. Propranolol was effective in treating cutaneous infantile haemangiomas in Thai children.
Techasatian L; Komwilaisak P; Panombualert S; Uppala R; Jetsrisuparb C
Acta Paediatr; 2016 Jun; 105(6):e257-62. PubMed ID: 26919396
[TBL] [Abstract][Full Text] [Related]
15. [Propranolol therapy for periocular and orbital infantile haemangiomas].
Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
[TBL] [Abstract][Full Text] [Related]
16. Propranolol for infantile haemangiomas: a review.
Starkey E; Shahidullah H
Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
[TBL] [Abstract][Full Text] [Related]
17. Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol.
Pope E; Chakkittakandiyil A; Lara-Corrales I; Maki E; Weinstein M
Br J Dermatol; 2013 Jan; 168(1):222-4. PubMed ID: 22762503
[No Abstract] [Full Text] [Related]
18. Successful treatment of infantile haemangiomas of the orbit with propranolol.
Li YC; McCahon E; Rowe NA; Martin PA; Wilcsek GA; Martin FJ
Clin Exp Ophthalmol; 2010 Aug; 38(6):554-9. PubMed ID: 20491798
[TBL] [Abstract][Full Text] [Related]
19. Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature.
Oksiuta M; Matuszczak E; Debek W; Dzienis-Koronkiewicz E; Hermanowicz A
J Matern Fetal Neonatal Med; 2016; 29(1):64-8. PubMed ID: 25385271
[TBL] [Abstract][Full Text] [Related]
20. Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study.
Tiwari P; Pandey V; Gangopadhyay AN; Sharma SP; Gupta DK
Oral Maxillofac Surg; 2016 Mar; 20(1):73-7. PubMed ID: 26481918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
